Age: 83.0
Sex: F
Vaccine: RSV
Symptoms: Malaise, Nasopharyngitis, Nausea, Productive cough, SARS-CoV-2 test negative
Clinical narrative: Chills; Sneezing; Headache; Cold (disease); overload of phlegm in throat; eyes infected; COVID-like symptoms; The patient had dry cough that lasted for 2 weeks; Joint pain; Nausea; This non-serious case was reported by a consumer via call center representative and described the occurrence of covid-19 in a 83-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   The patient's past medical history included shingles and asthma. Previously administered products included Prevnar. Concurrent medical conditions included type ii diabetes mellitus.   On 13-OCT-2023, the patient received the 1st dose of Arexvy (left deltoid). In OCT-2023, 1 week after receiving Arexvy, the patient experienced covid-19 (Verbatim: COVID-like symptoms), dry cough (Verbatim: The patient had dry cough that lasted for 2 weeks), chills (Verbatim: Chills), sneezing (Verbatim: Sneezing), headache (Verbatim: Headache), cold (Verbatim: Cold (disease)), phlegm (Verbatim: overload of phlegm in throat) and eye infection (Verbatim: eyes infected). On an unknown date, the patient experienced joint pain (Verbatim: Joint pain) and nausea (Verbatim: Nausea). The outcome of the covid-19, chills, sneezing, headache, cold, phlegm and eye infection were resolved and the outcome of the dry cough was resolved (duration 2 weeks) and the outcome of the joint pain and nausea were resolved (duration 3 hrs).   It was unknown if the reporter considered the covid-19, dry cough, chills, sneezing, headache, cold, phlegm, eye infection, joint pain and nausea to be related to Arexvy.     It was unknown if the company considered the covid-19, dry cough, chills, sneezing, headache, cold, phlegm, eye infection, joint pain and nausea to be related to Arexvy.   Additional Information: GSK Receipt Date: 14-NOV-2023 The reporter was the patient. The reporter stated that week after gsk shot, the patient had worst cold-felt like every toxin came out-never had a temp but had lots of dry coughing through out. Many Covid-like symptoms:overload of phlegm in throat, headache, dry cough( almost throughout) eyes infected, sneezing, chills,went through 4 boxes of tissues at end of second week, felt better. The patient did all the things, she usually do when sick. The patient stated that if this was from shot, she was truly grateful but it was hell going through it. This agent made an outbound call to gather further information. The GSK shot was clarified as AREXVY.  After receiving the vaccine, the patient experienced nausea and joint pain which went away after three hours. After 1 week, the patient began experiencing COVID-like symptoms. The patient stated she tested for COVID twice but each time was the result was negative. The patient never had a temperature and never experienced such a cold with any other vaccine. The patient had dry cough that lasted for 2 weeks. The patient inhaled steam to alleviate symptoms. The patient felt fabulous now. The reporter consented to follow up. Depending on the weather she could have a tiny bit of Asthma. The term "eyes infected" was not clarified. The patient referred to her symptoms as a Cold (disease), as well as COVID-like symptoms.